Abstract
The aim of the study was to assess the frequencies of the hereditary hemochromatosis HFE mutations C282Y, H63D, and S65C in the population in the Faroe Islands. The series comprised 200 randomly selected blood donors of Faroese heritage. The frequency of the C282Y, H63D, and S65C mutations on the HFE gene was assessed by genotyping using the polymerase chain reaction (PCR) technique and calculated from direct allele counting. We found no C282Y homozygous subjects; 28 (14.0%) subjects were C282Y heterozygous and four subjects were C282Y/H63D compound heterozygous (2.0%). The C282Y allele frequency was 8.0% (95% CI 5.3–10.7%). The series contained three (1.5%) H63D homozygous subjects and 60 (30.0%) H63D heterozygous subjects. The H63D allele frequency was 17.5% (95% CI 13.8–21.2%). There were four (2.0%) S65C heterozygous subjects. The S65C allele frequency was 1.0% (95% CI 0.3–2.5%). The frequency of the C282Y mutation is high in Faroese blood donors, being close to and not significantly different from the frequencies reported in other Scandinavian countries: Denmark 5.7%, Norway 6.6%, Iceland 5.1%, and Sweden 6.1%. The frequency of the H63D mutation in Faroese subjects is significantly higher than the frequency in Denmark 12.8% (p=0.007), Iceland 10.9% (p=0.003), and Sweden 12.4% (p=0.015), but not from the frequency in Norway 11.2% (p=0.063). The frequency of the S65C mutation in Faroese subjects is not significantly different from the frequencies in Denmark 1.5% and Sweden 1.6%. Screening of larger groups of the Faroese population for HFE mutations especially C282Y should be considered in order to establish the penetrance.
Similar content being viewed by others
References
Bothwell TH, Charlton RW, Motulsky AG (1995) Hemochromatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The molecular and metabolic basis of inherited disease. McGraw-Hill, New York, pp 2237–2269
Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110:1107–1119
Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K (2001) Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 80:737–744
Feder JN, Gnirke A, Thomas W, et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408
Milman N (2000) Inheritance of hemochromatosis: family studies. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology, diagnosis and treatment. Cambridge University Press, Cambridge, UK, pp 15–41
Worwood M (1998) Haemochromatosis. Clin Lab Haematol 20:65–75
Koefoed P, Dalhoff K, Dissing J, Kramer I, Milman N, et al. (2002) HFE mutations and hemochromatosis in Danish patients admitted for HFE genotyping. Scand J Clin Lab Invest 62:527–535
Milman N, Koefoed P, Pedersen P, Nielsen FC, Ejberg H (2003) Frequency of the HFE C282Y and the H63D alleles in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods. Eur J Haematol 71:403–407
Simonsen K, Dissing J, Rudbeck L, Schwartz M (1999) Rapid and simple determination of hereditary haemochromatosis mutations by multiplex PCR-SSCP: detection of a new polymorphic mutation. Ann Hum Genet 63:193–197
Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandsen M, et al. (2001) Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 358:1405–1409
Milman N, Pedersen P, Ovesen L, Melsen GV, Fenger K (2004) Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes. Ann Hematol, in press
Distante S, Berg JP, Lande K, Haug E, Bell H (2000) HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut 47:575–579
Cardoso EM, Stal P, Hagen K, Cabeda JM, et al. (1998) HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 243:203–208
Undlien DE, Bell H, Heier HE, Akselsen HE, Thorsby E (1998) Genetic diagnostic test for hemochromatosis. Tidsskr Nor Laegeforen 118:238–240
Beckman LE, Sjoberg K, Eriksson S, Beckman L (2001) Haemochromatosis gene mutations in Finns, Swedes and Swedish Saamis. Hum Hered 52:110–112
Holmström P, Marmur J, Eggertsen G, Gafvels M, Stal P (2002) Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 51:723–730
Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT (1999) Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 100:1274–1279
Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278
Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Nørgaard-Pedersen B, Robson KJ (1999) A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 13:154–159
Milman N (1991) Hereditary haemochromatosis in Denmark 1950–1985. Clinical, biochemical and histological features in 179 patients and 13 preclinical cases. Dan Med Bull 38:385–393
Milman N, Pedersen P, á Steig T, Melsen GV (2003) Frequency of the hereditary hemochromatosis allele in different populations. Comparison between previous phenotypic methods and novel genotypic methods. Int J Hematol 77:48–54
Jackson HA, Carter K, Guttrigde MG, et al. (1999) Haemochromatosis—prevalence and penetrance in blood donors resident in Wales. Blood 93 [Suppl 1]:407A
Wiggers P, Dalhøj J, Kiaer H, et al. (1991) Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 230:265–270
Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64:36–47
Arge SV (2000) Vikings in the Faeroe Islands. In: Fitzhugh WW, Ward EI (eds) Vikings. The North Atlantic saga. Smithsonian Institution Press, Washington, pp 154–163
Ewald H, Wang AG, Vang M, Mors O, Nyegaard M, Kruse TA (1999) A haplotype-based study of lithium responding patients with bipolar affective disorder in the Faroe Islands. Psychiatr Genet 9:23–34
Milman N, Graudal N, Nielsen LS, et al. (1990) Family studies of hereditary hemochromatosis in Denmark and the Faroe Islands. Hum Genet 85:228–232
Milman N, Thomsen H, Mathiassen B (1990) Serum ferritin, iron status and plasma ascorbic acid in 40- to 49-year-old males in the Faroe Islands. Scand J Clin Lab Invest 50:559–564
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Milman, N., á Steig, T., Koefoed, P. et al. Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faroe Islands. Ann Hematol 84, 146–149 (2005). https://doi.org/10.1007/s00277-004-0865-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-004-0865-8